• Aconitase Activity Colorimetric Assay Kit Guide

  2026-09-12

  Learn how to use the Aconitase Activity Colorimetric Assay Kit to connect TCA-cycle function, oxidative injury, and immune-cell metabolism. The workflow emphasizes practical controls, quantitative normalization, and complementary interpretation alongside the CD28-ARS2-PKM findings in activated CD8+ T cells.

• Limb Organoids Reveal How AER Signaling Organizes Fate

  2026-09-12

  The reference preprint introduces mouse embryonic stem cell-derived limb organoids, or budoids, that combine apical ectodermal ridge-like, surface ectoderm, mesodermal, and fibroblast-like properties. Its central finding is that AER-like cells do more than provide developmental signals: they coordinate local cell-fate support with tissue polarization, enabling cartilage formation at a distance.

• AP20187: Dimerization Control for Tumor-Stroma Studies

  2026-09-11

  AP20187 is a chemical inducer of dimerization that can provide temporal control over engineered signaling systems. This article develops a distinct assay strategy connecting conditional signaling to senescent cancer-associated fibroblast biology and immune suppression in breast tumors.

• Maridomycin Macrolide Activity: In Vitro and In Vivo

  2026-09-11

  The reference study established maridomycin as a broad-acting macrolide antibiotic with strong activity against many Gram-positive organisms and selected Gram-negative pathogens. By combining susceptibility testing, resistance experiments, bactericidal measurements, protein-binding analysis, and mouse infection models, it connected in vitro behavior with therapeutic activity while identifying important limitations related to cross-resistance.

• 5-(N,N-dimethyl)-Amiloride: NHE1 Assay Guide

  2026-09-10

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to separate Na+/H+ exchanger-dependent pH and sodium transport from downstream endothelial, cardiac, and hepatic phenotypes. This workflow combines isoform-aware concentration design with direct pH, sodium, permeability, and signaling readouts for more defensible mechanism studies.

• Serine/Glycine-Free Diet, Immunity, and PD-L1 Lactylation

  2026-09-10

  A 2024 Cell Metabolism study shows that serine/glycine restriction can inhibit colorectal cancer growth and increase cytotoxic T-cell accumulation, while also enabling immune escape through PD-L1 lactylation. Its preclinical findings and single-arm phase I feasibility data support further evaluation of diet–immunotherapy combinations, but randomized validation and mechanistic refinement remain necessary.

• Cathepsin B inhibitor CA-074: Practical Workflow

  2026-09-09

  CA-074 provides a selective biochemical tool for testing cathepsin B involvement in protease activity, cancer metastasis, neurotoxicity, and immune response modulation. This guide applies product-dossier specifications to assay and cell-based planning, while separating those values from workflow recommendations and avoiding claims of clinical efficacy or directly matched paper outcomes.

• PTEN mRNA Delivery to Reverse Trastuzumab Resistance

  2026-09-09

  The reference study developed tumor-microenvironment-responsive nanoparticles for systemic PTEN mRNA delivery in trastuzumab-resistant HER2-positive breast cancer. By restoring PTEN expression and suppressing constitutive PI3K/Akt signaling, the platform improved the biological response to trastuzumab and inhibited tumor progression in preclinical models.

• S63845 MCL1 Inhibitor: Apoptosis Workflow

  2026-09-08

  Build a mechanism-led apoptosis workflow around S63845 rather than relying on viability data alone. The approach combines dose-response testing, BAX/BAK pathway validation, and GET3/MCL1 perturbation to distinguish target dependence from nonspecific toxicity.

• Pseudo-modified uridine triphosphate in IVT

  2026-09-07

  Learn how Pseudo-UTP can be evaluated as a controlled UTP substitute for RNA synthesis, from reaction setup through cellular performance testing. The workflow emphasizes matched controls, pseudouridine-specific quality checks, and troubleshooting that separates nucleotide effects from template, purification, and delivery variables.

• Dasatinib Monohydrate: NET-Aware CML Research

  2026-09-07

  Dasatinib Monohydrate supports resistance-focused kinase studies and NET-aware chronic myeloid leukemia research. This article explains how to integrate BCR-ABL pharmacology with neutrophil extracellular trap measurements without overinterpreting TKI effects.

• Ferroptosis Signature and Atorvastatin in HCC

  2026-09-05

  A 2025 study combined ferroptosis-related transcriptomics, survival modeling, Connectivity Map screening, and experimental validation to develop a four-gene prognostic signature for hepatocellular carcinoma (HCC) and identify Atorvastatin as a potential ferroptosis-inducing agent. The findings support a biomarker-guided research strategy, while remaining preclinical and requiring mechanistic and clinical validation.

• Mouse Tissue Lysis Kit (K1038) Workflow

  2026-09-05

  The Mouse Tissue Lysis Kit (K1038) prepares mouse tissue lysates for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for scientific molecular biology research and assay development, not diagnostic, clinical, or medical use.

• Triiodothyronine: Mechanism-First Assay Design

  2026-09-04

  Triiodothyronine (T3) can serve as a controlled perturbation for thyroid hormone receptor activation and mechanistic cellular assays. This article connects T3 study design with lessons from spatially concentrated base editing, emphasizing localization, orthogonal readouts, and experimental boundaries.

• EZ Cap™ Human PTEN mRNA (ψUTP) Guide

  2026-09-04

  EZ Cap™ Human PTEN mRNA (ψUTP) is an in vitro transcribed mRNA reagent encoding human PTEN with a Cap 1 structure, pseudouridine triphosphate, and a poly(A) tail. These design features support translation, mRNA stability enhancement, and experimental studies of PI3K/Akt signaling pathway inhibition, including cancer research.

7937 records 1/530 page Next 12345 下5页 Last page